Stephanie Loewen

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial

M. Schultze-Mosgau, B. Rohde, T. Zimmermann, 2020, British journal of clinical pharmacology.

Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers

M. Boettcher, C. Becker, Stephanie Loewen, 2020, Clinical Pharmacokinetics.

Results From Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Inhibitory Effect of Finerenone on the Drug Transporters BCRP, OATP1B1, and OATP1B3

R. Heinig, J. Nagelschmitz, Sebastian Wertz, 2022, European Journal of Drug Metabolism and Pharmacokinetics.

Results from in vitro and in vivo studies evaluating the bioavailability, effects of food, and administration as crushed tablet suspension on vericiguat pharmacokinetics

M. Boettcher, W. Mueck, C. Becker, 2022, AAPS Open.

Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug–Drug Interaction Studies In Vitro and In Vivo

R. Heinig, J. Nagelschmitz, M. Gerisch, 2018, European Journal of Drug Metabolism and Pharmacokinetics.

Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects

M. Boettcher, W. Mueck, C. Becker, 2020, European Journal of Clinical Pharmacology.

Results from Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Effect of Finerenone on the Pharmacokinetics of Comedications

Michaela Bairlein, R. Heinig, J. Nagelschmitz, 2020, European Journal of Drug Metabolism and Pharmacokinetics.

Results From Phase I Studies Investigating the Dose Linearity of Finerenone Tablets and the Influence of Food or pH-Modifying Comedications on its Pharmacokinetics in Healthy Male Volunteers

R. Heinig, J. Nagelschmitz, Stephanie Loewen, 2022, European Journal of Drug Metabolism and Pharmacokinetics.

Determination of finerenone - a novel, selective, nonsteroidal mineralocorticoid receptor antagonist - in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study in venous and capillary human plasma.

R. Heinig, Stephanie Loewen, G. Rohde, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug–Drug Interaction Studies In Vitro and In Vivo

R. Heinig, J. Nagelschmitz, M. Gerisch, 2018, European Journal of Drug Metabolism and Pharmacokinetics.

Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment

K. Lasseter, T. Marbury, M. Schultze-Mosgau, 2020, Journal of clinical pharmacology.